Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.14%
1,102.18
+1.57
+0.14%
1,100.611,106.151,114.281,098.89
SIXC
Communications
SIXC
Communications
SIXC
+0.64%
616.24
+3.94
+0.64%
612.30612.30616.40612.30
SIXE
Energy
SIXE
Energy
SIXE
+1.21%
1,189.72
+14.26
+1.21%
1,175.461,182.971,193.951,182.97
SIXI
Industrials
SIXI
Industrials
SIXI
-0.20%
1,725.69
-3.43
-0.20%
1,729.121,731.371,754.071,718.58
SIXM
Financials
SIXM
Financials
SIXM
-0.17%
643.62
-1.11
-0.17%
644.73645.31649.16642.15
SIXR
Staples
SIXR
Staples
SIXR
+0.33%
829.79
+2.70
+0.33%
827.09828.05833.90827.27
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.66%
213.40
-1.42
-0.66%
214.82214.82216.61212.62
SIXT
Technology
SIXT
Technology
SIXT
+2.27%
3,185.92
+70.75
+2.27%
3,115.173,142.773,186.203,133.07
SIXU
Utilities
SIXU
Utilities
SIXU
-0.16%
908.94
-1.49
-0.16%
910.43915.18923.94906.03
SIXV
Health care
SIXV
Health care
SIXV
+0.30%
1,478.96
+4.46
+0.30%
1,474.501,480.841,491.461,475.55
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.02%
2,405.36
-0.51
-0.02%
2,405.872,415.572,420.792,398.99
NATCOPHARM:NSE
Natco Pharma Ltd
₹1,072.00
+1.55%
(+16.35) 1D
Apr 22, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for NATCOPHARM...
Open
₹1,058.05
High
₹1,078.90
Low
₹1,042.25
Mkt. cap
191.91B
Avg. vol.
820.28K
Volume
501.98K
Dividend
0.47%
Quarterly dividend
₹1.25
Ex dividend date
Feb 18, 2026
P/E ratio
12.33
52-wk high
₹1,134.85
52-wk low
₹775.00
EPS
₹86.94
Shares outstanding
182.26M
No. of employees
4K
News stories
From sources across the web
Profile
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations, active pharmaceutical ingredients and agrochemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs at affordable prices. Wikipedia
About Natco Pharma Ltd
CEORajeev Nannapaneni
Employees4.2K
Founded1981
HeadquartersBanjara Hills, Telangana, India
SectorPharmaceutical industry
Last report
Feb 12, 2026
Fiscal Period
Q3 2026
Normalized EPS / Estimate
8.46/ (8.67 est.)INR
-2.38%miss
Revenue / Estimate
6.47B/ (7.06B est.)INR
-8.37%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
12.23B
13.29B
13.63B
6.47B
Cost of goods sold
2.87B
2.33B
1.70B
1.33B
Cost of revenue
2.87B
2.33B
1.70B
1.33B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.64B
1.69B
2.00B
1.59B
Operating expense
4.81B
5.82B
6.66B
4.02B
Total operating expenses
7.68B
8.16B
8.36B
5.35B
Operating income
4.55B
5.13B
5.27B
1.12B
Other non operating income
-2.61B
617.00M
1.00B
581.00M
EBT including unusual items
5.06B
5.72B
6.14B
1.72B
EBT excluding unusual items
4.01B
5.72B
6.14B
1.72B
Income tax expense
999.00M
916.00M
958.00M
207.00M
Effective tax rate
19.75%
16.02%
15.61%
12.03%
Other operating expenses
2.18B
3.56B
4.14B
1.96B
Net income
4.07B
4.81B
5.18B
1.52B
Net profit margin
33.24%
36.17%
38.03%
23.40%
Earnings per share
22.70
26.84
28.94
8.46
Interest and investment income
1.90B
-
-
-
Interest expense
-33.00M
-32.00M
-131.00M
-95.00M
Net interest expenses
1.87B
-32.00M
-131.00M
-95.00M
Depreciation and amortization charges
983.00M
576.00M
524.00M
462.00M
EBITDA
5.00B
5.72B
5.82B
1.57B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more